Product Overview
CJC-1295 (5mg) and Ipamorelin (5mg) are combined into a single peptide blend for controlled in vitro research applications. CJC-1295 is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue. Together, they are commonly studied for their synergistic effects on growth hormone signaling and endocrine pathway modulation in experimental models.
Specifications
- Total Unit Size: 10mg (5mg CJC-1295 + 5mg Ipamorelin)
- Form: Lyophilized powder
- Storage: Store in a cool, dry environment. After reconstitution, maintain between 2°C–8°C under sterile conditions
Research Applications
This peptide blend is commonly utilized in in vitro studies involving:
- Growth hormone signaling and secretion pathways
- Cellular metabolism and protein synthesis regulation
- Endocrine system communication models
- Tissue repair and recovery-related signaling research
Usage Notes
- Bacteriostatic water is sold separately
- Supplied in powdered form for reconstitution prior to use
Intended Use
This product is intended strictly for in vitro laboratory research by qualified professionals. It is not approved for human or veterinary use and must not be used in food, pharmaceuticals, cosmetics, or diagnostic applications.
Disclaimer & Terms
This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. All sales are final. By purchasing, the buyer confirms they are qualified to handle research compounds and assumes full responsibility for proper handling, storage, and compliance with all applicable laws and regulations.
Reviews
There are no reviews yet.